Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Combating COVID-19 with integrated traditional Chinese and Western medicine in China
Liqiang Ni, Lili Chen, Xia Huang, et al.
Acta Pharmaceutica Sinica B (2020) Vol. 10, Iss. 7, pp. 1149-1162
Open Access | Times Cited: 154

Showing 26-50 of 154 citing articles:

Comprehensive profiling and characterization of the absorbed components and metabolites in mice serum and tissues following oral administration of Qing-Fei-Pai-Du decoction by UHPLC-Q-Exactive-Orbitrap HRMS
Wei Liu, Jian Huang, Feng Zhang, et al.
Chinese Journal of Natural Medicines (2021) Vol. 19, Iss. 4, pp. 305-320
Open Access | Times Cited: 30
Structural characterization and protective effect of Lonicerae flos polysaccharide on cyclophosphamide-induced immunosuppression in mice
Chao Han, Ying Wang, Ruiying Liu, et al.
Ecotoxicology and Environmental Safety (2022) Vol. 230, pp. 113174-113174
Open Access | Times Cited: 19
Effect of Qingfei Paidu decoction combined with Western medicine treatments for COVID-19: A systematic review and meta-analysis
Lei Zhang, Yan Ma, Nannan Shi, et al.
Phytomedicine (2022) Vol. 102, pp. 154166-154166
Open Access | Times Cited: 19
Traditional Chinese Medicines Against COVID-19
Chang-Liang Yao, Wenlong Wei, Jian-Qing Zhang, et al.
World Journal of Traditional Chinese Medicine (2022) Vol. 8, Iss. 3, pp. 279-313
Open Access | Times Cited: 19
Research and development of Chinese anti-COVID-19 drugs
Xiwei Ji, Xiangrui Meng, Xiao Zhu, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 12, pp. 4271-4286
Open Access | Times Cited: 19
Network Pharmacology and Comparative Transcriptome Reveals Biotargets and Mechanisms of Curcumol Treating Lung Adenocarcinoma Patients With COVID-19
Lu Yang, Hao Xiong, Xin Li, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 18
Research trends on traditional Chinese medicine and acute pancreatitis: A bibliometric analysis from 2007 to mid-2023
Wang-peng Lan, Wen Guo, Xin Zhou, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e25659-e25659
Open Access | Times Cited: 3
Enhancing traditional Chinese medical named entity recognition with Dyn-Att Net: a dynamic attention approach
Jingming Hou, Saidah Saad, Nazlia Omar
PeerJ Computer Science (2024) Vol. 10, pp. e2022-e2022
Open Access | Times Cited: 3
Traditional Chinese medicine for combating COVID-19
Kaixian Chen, Hongzhuan Chen
Frontiers of Medicine (2020) Vol. 14, Iss. 5, pp. 529-532
Open Access | Times Cited: 30
The COVID-19 Pandemic and the Relevance of Ayurveda's Whole Systems Approach to Health and Disease Management
Unnikrishnan Payyappallimana, Kishor Patwardhan, Prasad Mangalath, et al.
The Journal of Alternative and Complementary Medicine (2020) Vol. 26, Iss. 12, pp. 1089-1092
Closed Access | Times Cited: 30
Pharmacokinetics-based identification of pseudoaldosterogenic compounds originating from Glycyrrhiza uralensis roots (Gancao) after dosing LianhuaQingwen capsule
Xiao-fang Lan, Olajide E. Olaleye, Jun-lan Lu, et al.
Acta Pharmacologica Sinica (2021) Vol. 42, Iss. 12, pp. 2155-2172
Open Access | Times Cited: 26
Traditional Chinese medicine for treatment of novel infectious diseases: Current status and dilemma
Fanghua Qi, Wei Tang
BioScience Trends (2021) Vol. 15, Iss. 4, pp. 201-204
Open Access | Times Cited: 25
Updated pharmacological effects of Lonicerae japonicae flos, with a focus on its potential efficacy on coronavirus disease–2019 (COVID-19)
Hui Zhao, Sha Zeng, Li Chen, et al.
Current Opinion in Pharmacology (2021) Vol. 60, pp. 200-207
Open Access | Times Cited: 25
Adverse Cardiovascular Effects of Anti-COVID-19 Drugs
Dongling Liu, Xiang Zeng, Zufeng Ding, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 25
Comparison of the guidelines on good agricultural and collection practices in herbal medicine of the European Union, China, the WHO, and the United States of America
Mingxu Zhang, Congcong Wang, Ru Zhang, et al.
Pharmacological Research (2021) Vol. 167, pp. 105533-105533
Closed Access | Times Cited: 23
A novel transfer learning model for traditional herbal medicine prescription generation from unstructured resources and knowledge
Zhi Liu, Changyong Luo, Dianzheng Fu, et al.
Artificial Intelligence in Medicine (2021) Vol. 124, pp. 102232-102232
Closed Access | Times Cited: 23
The efficacy and safety of combined chinese herbal medicine and western medicine therapy for COVID-19: a systematic review and meta-analysis
Lu Li, Hongliang Xie, Ling Wang, et al.
Chinese Medicine (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 16
Clinical efficacy, pharmacodynamic components, and molecular mechanisms of antiviral granules in the treatment of influenza: A systematic review
Juan Su, Xinming Chen, Yi-ling Xie, et al.
Journal of Ethnopharmacology (2023) Vol. 318, pp. 117011-117011
Closed Access | Times Cited: 9
Network pharmacology and RNA-sequencing reveal the molecular mechanism of Xuebijing injection on COVID-19-induced cardiac dysfunction
Dingdong He, Xiaokang Zhang, Xinyu Zhu, et al.
Computers in Biology and Medicine (2021) Vol. 131, pp. 104293-104293
Open Access | Times Cited: 22
Euphorbia hirta as a gold mine of high-value phytochemicals: A comprehensive review of its pharmacological activities and possible role against SARS-CoV-2
Aadil Khursheed, Vikrant Jain, Ab Rouf Wani
Biomedical Research and Therapy (2022) Vol. 9, Iss. 2, pp. 4930-4949
Open Access | Times Cited: 15
Evidence construction of Huangkui capsule against chronic glomerulonephritis: A systematic review and network pharmacology
Yao Dai, Xixi Chen, Heng Yang, et al.
Phytomedicine (2022) Vol. 102, pp. 154189-154189
Closed Access | Times Cited: 14
A Comparison of Etiology, Pathogenesis, Vaccinal and Antiviral Drug Development between Influenza and COVID-19
Junhao Luo, Zhuohan Zhang, Zhao Song, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6369-6369
Open Access | Times Cited: 8
Two Resveratrol Oligomers Inhibit Cathepsin L Activity to Suppress SARS-CoV-2 Entry
Chenghai Wang, Xiansheng Ye, Chengchao Ding, et al.
Journal of Agricultural and Food Chemistry (2023) Vol. 71, Iss. 14, pp. 5535-5546
Open Access | Times Cited: 8
Lonicera japonica Thunb. as a promising antibacterial agent for Bacillus cereus ATCC14579 based on network pharmacology, metabolomics, and in vitro experiments
Nan Xu, Li-hua Du, Yanchao Chen, et al.
RSC Advances (2023) Vol. 13, Iss. 23, pp. 15379-15390
Open Access | Times Cited: 8
Phytoconstituents profiling of indigenous herbal drugs and its in vitro microbial, in silico biological examination against Severe acute respiratory syndrome coronavirus 2
T. H. Mohamed Ahadu Shareef, Manal Masood, Navabshan Irfan, et al.
World Journal of Traditional Chinese Medicine (2024) Vol. 10, Iss. 1, pp. 121-136
Open Access | Times Cited: 2

Scroll to top